Arlington, MA, United States of America

Kutlu Goksu Elpek

This inventor holds 6 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Jounce Therapeutics, Inc., Obsidian Therapeutics, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kutlu Goksu Elpek. Retrieved from https://idiyas.com/inventor/kutlu-goksu-elpek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Kutlu Goksu Elpek

Introduction: Kutlu Goksu Elpek is a pioneering inventor based in Arlington, MA, known for her groundbreaking contributions to the field of technology.

Latest Patents: Kutlu Goksu Elpek holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Kutlu Goksu Elpek has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout her career, Kutlu Goksu Elpek has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life and make a lasting impact on society.

Conclusion: Kutlu Goksu Elpek's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…